Sigyn Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sigyn Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2014 to Q3 2024.
  • Sigyn Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$808K, a 25.8% decline year-over-year.
  • Sigyn Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$2.76M, a 24.8% decline year-over-year.
  • Sigyn Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$2.46M, a 14.3% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$2.15M, a 6.92% decline from 2021.
  • Sigyn Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$2.01M, a 119% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.76M -$808K -$166K -25.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$2.59M -$603K -$28.8K -5.02% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$2.56M -$630K -$109K -20.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$2.46M -$717K -$246K -52.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$2.21M -$643K -$109K -20.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$2.1M -$574K -$41.2K -7.74% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$2.06M -$521K +$88K +14.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$2.15M -$472K +$119K +20.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$2.27M -$534K +$39.7K +6.93% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$2.31M -$533K -$91K -20.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$2.22M -$609K -$207K -51.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2.01M -$591K -$246K -71.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$1.76M -$573K -$370K -182% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.39M -$442K -$266K -151% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$1.13M -$402K -$209K -108% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$916K -$345K -$343K -22130% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$573K -$203K -$80.3K -65.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$493K -$176K -$74.6K -73.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$419K -$193K -$24.1K -14.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$394K -$1.55K +$241K +99.4% Oct 29, 2019 Dec 31, 2019 10-K 2021-04-06
Q3 2019 -$635K -$123K +$119K +49.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$754K -$101K +$132K +56.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$885K -$169K +$119K +41.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$1M -$242K +$247K +50.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$1.25M -$241K +$339K +58.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.59M -$233K +$382K +62.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$1.97M -$288K +$55.9K +16.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-19
Q4 2017 -$2.03M -$489K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$580K -$251K -76.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$615K -$88.4K -16.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$344K +$369K +51.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 -$2.37M -$329K +$487K +59.7% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-14
Q2 2016 -$2.86M -$527K -$43.6K -9.03% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 -$2.81M -$713K -$561K -369% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
Q4 2015 -$2.25M -$802K Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 -$817K -$738K -942% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$483K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$152K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 -$78.3K Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.